Your session is about to expire
← Back to Search
mHealth App for Psychosis
Study Summary
This trial will test a mobile health app to help young people at risk for psychosis to improve their health and connect to treatment options.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I haven't taken antipsychotic medication or attended multiple psychotherapy sessions in the last 3 months.I have been in mental health treatment recently, either through medication or therapy.I own an iPhone.I am between 18 and 30 years old.It's been less than 5 years since my first signs of psychosis.
- Group 1: NORTH
- Group 2: NORTH "Lite"
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is eligibility for this trial restricted to those aged 70 or below?
"The requirements to partake in this medical study are strict, with the age range of participants spanning from 18 to 30 years. In contrast, there are 123 investigations catered for minors and 282 directed at patients over 65."
What is the aggregate tally of individuals participating in this clinical investigation?
"Affirmative. Clinicaltrials.gov states that this research is continuing to recruit participants, with the trial having first been posted on June 15th 2023 and most recently updated July 24th 2023. The study requires 60 patients from a single site."
Are there any vacancies left for the participants in this experiment?
"As per information on clinicaltrials.gov, this experiment is currently recruiting patients with the first posting date being June 15th 2023. The details of the trial have been recently adjusted, as evidenced by its most recent amendment occurring July 24th 2023."
Is my profile compatible with the parameters of this trial?
"This trial is seeking 60 participants aged between 18 and 30 that are at a heightened risk of psychosis, as indicated by the Prodromal Questionnaire Brief (Savill et al., 2018) and Community Assessment of Psychic Experiences (CAPE-P15; Jaya et al., 2021 & Bukenaite et al., 2017). Other requirements for enrollment include: US residency, no more than 5 years since first psychotic episode, possession of an iPhone device, and lack of engagement in specialty mental health treatment. Additionally, online data collection checks must be completed to confirm symptomology (Moritz et al.: 2013)."
What is the primary aim of this research?
"The primary outcome being assessed over a baseline, 6 week and 12 week time frame is an alteration of treatment-seeking attitudes. Additionally, the secondary outcomes include modifications to recovery as per the CHOICE-SF scale, changes in functioning using SDS and intervention acceptability/usability gauged by means of a modified System Usability Scale."
Share this study with friends
Copy Link
Messenger